Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France.
CONCLUSIONS: In France, GNV has a significant impact in terms of public health benefits and may be considered cost-effective compared with GOV at low and high coverage rates.
PMID: 33261895 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Majed L, Bresse X, El Mouaddin N, Schmidt A, Daniels VJ, Pavelyev A, Levy-Bachelot L, Elbasha E Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Anal Cancer | Boys | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Epidemiology | France Health | Genital Warts | Girls | International Medicine & Public Health | Science | Study | Vaccines | Warts